BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 27758112)

  • 1. Promyelocytic Leukemia Protein, a Protein at the Crossroad of Oxidative Stress and Metabolism.
    Tessier S; Martin-Martin N; de Thé H; Carracedo A; Lallemand-Breitenbach V
    Antioxid Redox Signal; 2017 Mar; 26(9):432-444. PubMed ID: 27758112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PML is a ROS sensor activating p53 upon oxidative stress.
    Niwa-Kawakita M; Ferhi O; Soilihi H; Le Bras M; Lallemand-Breitenbach V; de Thé H
    J Exp Med; 2017 Nov; 214(11):3197-3206. PubMed ID: 28931625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PML nuclear bodies, membrane-less domains acting as ROS sensors?
    Niwa-Kawakita M; Wu HC; Thé H; Lallemand-Breitenbach V
    Semin Cell Dev Biol; 2018 Aug; 80():29-34. PubMed ID: 29157919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of nuclear bodies in apoptosis signalling.
    Krieghoff-Henning E; Hofmann TG
    Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins.
    Sahin U; Ferhi O; Jeanne M; Benhenda S; Berthier C; Jollivet F; Niwa-Kawakita M; Faklaris O; Setterblad N; de Thé H; Lallemand-Breitenbach V
    J Cell Biol; 2014 Mar; 204(6):931-45. PubMed ID: 24637324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of component exchange at PML nuclear bodies.
    Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
    J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PML nuclear bodies: assembly and oxidative stress-sensitive sumoylation.
    Sahin U; de Thé H; Lallemand-Breitenbach V
    Nucleus; 2014; 5(6):499-507. PubMed ID: 25482067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3.
    Jeanne M; Lallemand-Breitenbach V; Ferhi O; Koken M; Le Bras M; Duffort S; Peres L; Berthier C; Soilihi H; Raught B; de Thé H
    Cancer Cell; 2010 Jul; 18(1):88-98. PubMed ID: 20609355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs.
    Peche LY; Scolz M; Ladelfa MF; Monte M; Schneider C
    Cell Death Differ; 2012 Jun; 19(6):926-36. PubMed ID: 22117195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Swine Promyelocytic Leukemia Isoform II Inhibits Pseudorabies Virus Infection by Suppressing Viral Gene Transcription in Promyelocytic Leukemia Nuclear Bodies.
    Yu C; Xu A; Lang Y; Qin C; Wang M; Yuan X; Sun S; Feng W; Gao C; Chen J; Zhang R; Tang J
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PML Nuclear bodies: the cancer connection and beyond.
    Abou-Ghali M; Lallemand-Breitenbach V
    Nucleus; 2024 Dec; 15(1):2321265. PubMed ID: 38411156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-step colocalization of MORC3 with PML nuclear bodies.
    Mimura Y; Takahashi K; Kawata K; Akazawa T; Inoue N
    J Cell Sci; 2010 Jun; 123(Pt 12):2014-24. PubMed ID: 20501696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory syncytial virus induces NRF2 degradation through a promyelocytic leukemia protein - ring finger protein 4 dependent pathway.
    Komaravelli N; Ansar M; Garofalo RP; Casola A
    Free Radic Biol Med; 2017 Dec; 113():494-504. PubMed ID: 29107745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral DNA Binding Protein SUMOylation Promotes PML Nuclear Body Localization Next to Viral Replication Centers.
    Stubbe M; Mai J; Paulus C; Stubbe HC; Berscheminski J; Karimi M; Hofmann S; Weber E; Hadian K; Hay R; Groitl P; Nevels M; Dobner T; Schreiner S
    mBio; 2020 Mar; 11(2):. PubMed ID: 32184235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CACUL1/CAC1 attenuates p53 activity through PML post-translational modification.
    Fukuda T; Kigoshi-Tansho Y; Naganuma T; Kazaana A; Okajima T; Tsuruta F; Chiba T
    Biochem Biophys Res Commun; 2017 Jan; 482(4):863-869. PubMed ID: 27889610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-terminal motifs in promyelocytic leukemia protein isoforms critically regulate PML nuclear body formation.
    Li C; Peng Q; Wan X; Sun H; Tang J
    J Cell Sci; 2017 Oct; 130(20):3496-3506. PubMed ID: 28851805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies.
    Liang YC; Lee CC; Yao YL; Lai CC; Schmitz ML; Yang WM
    Sci Rep; 2016 May; 6():26509. PubMed ID: 27211601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RING tetramerization is required for nuclear body biogenesis and PML sumoylation.
    Wang P; Benhenda S; Wu H; Lallemand-Breitenbach V; Zhen T; Jollivet F; Peres L; Li Y; Chen SJ; Chen Z; de Thé H; Meng G
    Nat Commun; 2018 Mar; 9(1):1277. PubMed ID: 29599493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PML nuclear bodies and chromatin dynamics: catch me if you can!
    Corpet A; Kleijwegt C; Roubille S; Juillard F; Jacquet K; Texier P; Lomonte P
    Nucleic Acids Res; 2020 Dec; 48(21):11890-11912. PubMed ID: 33068409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence.
    Ivanschitz L; Takahashi Y; Jollivet F; Ayrault O; Le Bras M; de Thé H
    Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14278-83. PubMed ID: 26578773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.